Premium
Psychedelic therapy: Fresh promise for mental health
Author(s) -
Bush Heidi
Publication year - 2020
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32207
Subject(s) - psilocybin , lysergic acid diethylamide , psychotherapist , mental health , psychology , psychiatry , depression (economics) , hallucinogen , medicine , receptor , serotonin , economics , macroeconomics
Psychedelic‐assisted psychotherapy is seeing a resurgence as a treatment approach for mental health disorders. It melds pharmacology and psychotherapy, using substances such as lysergic acid diethylamide (LSD) and psilocybin, under medical supervision, to treat conditions such as post‐traumatic stress disorder (PTSD) and extreme depression.